August 19, 2009 – Mennen Medical, a leading provider of patient monitors, cardiac catheterization and electrophysiology systems, said today Frost & Sullivan awarded Mennen Medical the 2009 European Patient Monitoring Technology Leadership of the Year Award. This prestigious award is bestowed upon the company that has demonstrated excellence in technology leadership within their industry. Frost & Sullivan presented the award to Mennen Medical for its innovative and advanced technological platform – the CIPAM, which is being used by Mennen Medical in its patient monitors and hemodynamic applications. The CIPAM (Configurable Isolated Physiological Acquisition Module) is Mennen's front end board, which features multiple acquisition units for measuring various physiological parameters. The technological advantage of the CIPAM is based on several years of development, resulting in a single board that includes all parameters' acquisition components. This enables a development of a wide range of new products that are compact and sizable and yet have the same powerful abilities of the current multiple boards used by other manufacturers. Mennen Medical has already developed applications with the CIPAM, among them the CFE, which is the front end of Mennen Medical's hemodynamic system, the VitaLogik 4X00, which is a portable compact patient monitor and the VitaLogik 5X00 – a mid-range bed side monitor. All these applications have gained FDA and CE clearances. Mennen Medical is planning to launch the VitaLogik 6X00 patient monitor by the end of 2009 – which is expected to be the leading "member" in the VitaLogik family. The VitaLogik bed-side patient monitoring line is considered to be a high-end line of products which provide a reliable and wide solution for critical to intermediate care patients from neonates to adults. By introducing the newly developed CIPAM board, Mennen Medical has established a new platform that will lead the way for the next generation of Mennen Medical's patient monitoring line, currently being developed by the company's research and development team. For more information: www.mennenmedical.com
If you enjoy this content, please share it with a colleague
Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Award
Related Content
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Continuous advances in critical patient care have enabled to develop efficient hemodynamic monitoring systems featuring ...
The overall trend in the cardiac output monitoring market is a movement toward noninvasive or minimally monitoring ...
December 1, 2020 — A recent publication demonstrated procedural efficiency for MitraClip transcatheter mitral valve ...
Beyond measuring blood flow, pressure, oxygen levels and other vital signs in the cardiac catheterization lab, current ...
September 18, 2017 — Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug ...
The current generation of hemodynamic monitoring systems can help catheterization labs electronically document the ...
April 1, 2016 — Siemens will unveil a revamped version of its established Sensis hemodynamic system at the 65 th Annual ...
Beyond measuring blood flow, pressure, oxygen levels and other vital signs in the cardiac catheterization lab, current ...